[HTML][HTML] CAR T cell immunotherapy beyond haematological malignancy
C Hupperetz, S Lah, H Kim, CH Kim - Immune network, 2022 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells, which express a synthetic receptor engineered to
target specific antigens, have demonstrated remarkable potential to treat haematological …
target specific antigens, have demonstrated remarkable potential to treat haematological …